Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Pancreatic Ductal × Long Interspersed Nucleotide Elements × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Pancreatic Ductal 1 Anophthalmia with pulmonary hypoplasia 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 Cetuximab 3 Bevacizumab 3 pembrolizumab 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 relacorilant 1 Long Interspersed Nucleotide Elements 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05475366 2026-02-18

PACsign

Institut Curie

Phase NA Recruiting

Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡